BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zollers B, Rhodes L, Heinen E. Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study. BMC Vet Res 2017;13:10. [PMID: 28056951 DOI: 10.1186/s12917-016-0925-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Johannes CM, Musser ML. Anorexia and the Cancer Patient. Vet Clin North Am Small Anim Pract 2019;49:837-54. [PMID: 31176457 DOI: 10.1016/j.cvsm.2019.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Paulin MV, Couronné L, Beguin J, Le Poder S, Delverdier M, Semin MO, Bruneau J, Cerf-Bensussan N, Malamut G, Cellier C, Benchekroun G, Tiret L, German AJ, Hermine O, Freiche V. Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease. BMC Vet Res 2018;14:306. [PMID: 30305106 DOI: 10.1186/s12917-018-1635-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
3 Salade L, Wauthoz N, Deleu M, Vermeersch M, De Vriese C, Amighi K, Goole J. Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia. Int J Nanomedicine 2017;12:8531-43. [PMID: 29238190 DOI: 10.2147/IJN.S147650] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
4 Ceron-Romero N, Taofeek N, Thomas A, Vroonland E, Sanmartin K, Verghese M, Heinen E, Vizcarra JA. Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus). Poult Sci 2021;100:101204. [PMID: 34182219 DOI: 10.1016/j.psj.2021.101204] [Reference Citation Analysis]
5 Matsumura N, Ono A, Akiyama Y, Fujita T, Sugano K. Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs. Pharmaceutics 2020;12:E844. [PMID: 32899235 DOI: 10.3390/pharmaceutics12090844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schalla MA, Stengel A. Pharmacological Modulation of Ghrelin to Induce Weight Loss: Successes and Challenges. Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1211-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 Smith AJ. Perspectives on Feeding and Nutrition. Vet Clin North Am Small Anim Pract 2019;49:501-17. [PMID: 30850306 DOI: 10.1016/j.cvsm.2019.01.014] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Wofford JA, Zollers B, Rhodes L, Bell M, Heinen E. Evaluation of the safety of daily administration of capromorelin in cats. J vet Pharmacol Therap 2018;41:324-33. [DOI: 10.1111/jvp.12459] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
9 Freeman LM. Cachexia and Sarcopenia in Companion Animals: An Under-Utilized Natural Animal Model of Human Disease. JCSM Rapid Communications 2018;1:1-17. [DOI: 10.1002/j.2617-1619.2018.tb00006.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Buckinx A, De Bundel D, Kooijman R, Smolders I. Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy. Biomedicines 2022;10:53. [DOI: 10.3390/biomedicines10010053] [Reference Citation Analysis]
11 Rhodes L, Zollers B, Wofford JA, Heinen E. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs. Vet Med Sci 2018;4:3-16. [PMID: 29468076 DOI: 10.1002/vms3.83] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]